201 related articles for article (PubMed ID: 27491495)
1. MYB expression: Potential role in separating adenoid cystic carcinoma (ACC) from pleomorphic adenoma (PA).
Moon A; Cohen C; Siddiqui MT
Diagn Cytopathol; 2016 Oct; 44(10):799-804. PubMed ID: 27491495
[TBL] [Abstract][Full Text] [Related]
2. LEF-1: Diagnostic utility in distinguishing basaloid neoplasms of the salivary gland.
Schmitt AC; Griffith CC; Cohen C; Siddiqui MT
Diagn Cytopathol; 2017 Dec; 45(12):1078-1083. PubMed ID: 28972308
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
Foo WC; Jo VY; Krane JF
Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
[TBL] [Abstract][Full Text] [Related]
4. MYB immunostaining is a useful ancillary test for distinguishing adenoid cystic carcinoma from pleomorphic adenoma in fine-needle aspiration biopsy specimens.
Pusztaszeri MP; Sadow PM; Ushiku A; Bordignon P; McKee TA; Faquin WC
Cancer Cytopathol; 2014 Apr; 122(4):257-65. PubMed ID: 24302647
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
[TBL] [Abstract][Full Text] [Related]
6. PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.
Avadhani V; Cohen C; Siddiqui MT
Acta Cytol; 2016; 60(3):240-5. PubMed ID: 27463119
[TBL] [Abstract][Full Text] [Related]
7. The PRKD1 E710D hotspot mutation is highly specific in separating polymorphous adenocarcinoma of the palate from adenoid cystic carcinoma and pleomorphic adenoma on FNA.
Andreasen S; Melchior LC; Kiss K; Bishop JA; Høgdall E; Grauslund M; Wessel I; Homøe P; Agander TK
Cancer Cytopathol; 2018 Apr; 126(4):275-281. PubMed ID: 29266837
[TBL] [Abstract][Full Text] [Related]
8. The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC).
Sun T; Akalin A; Dresser K; Fischer AH; Zuo T
Head Neck Pathol; 2021 Jun; 15(2):389-394. PubMed ID: 32661670
[TBL] [Abstract][Full Text] [Related]
9. MYB gene abnormalities t(6;9) in adenoid cystic carcinoma fine-needle aspiration biopsy using fluorescence in situ hybridization.
Hudson JB; Collins BT
Arch Pathol Lab Med; 2014 Mar; 138(3):403-9. PubMed ID: 24576033
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical features of lacrimal gland epithelial tumors.
Mendoza PR; Jakobiec FA; Krane JF
Am J Ophthalmol; 2013 Dec; 156(6):1147-1158.e1. PubMed ID: 23972314
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls of fine-needle aspiration cytology of parotid membranous basal cell adenoma-A review of pitfalls in FNA cytology of salivary gland neoplasms with basaloid cell features.
Jurczyk M; Peevey JF; Vande Haar MA; Lin X
Diagn Cytopathol; 2015 May; 43(5):432-7. PubMed ID: 25431027
[TBL] [Abstract][Full Text] [Related]
12. MYB Labeling by Immunohistochemistry Is More Sensitive and Specific for Breast Adenoid Cystic Carcinoma than MYB Labeling by FISH.
Poling JS; Yonescu R; Subhawong AP; Sharma R; Argani P; Ning Y; Cimino-Mathews A
Am J Surg Pathol; 2017 Jul; 41(7):973-979. PubMed ID: 28498281
[TBL] [Abstract][Full Text] [Related]
13. Differences in MYB expression and gene abnormalities further confirm that salivary cribriform basal cell tumors and adenoid cystic carcinoma are two distinct tumor entities.
Tian Z; Li L; Zhang CY; Gu T; Li J
J Oral Pathol Med; 2016 Oct; 45(9):698-703. PubMed ID: 26711587
[TBL] [Abstract][Full Text] [Related]
14. MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinoma.
Tadi S; Cheung VK; Lee CS; Nguyen K; Luk PP; Low TH; Palme C; Clark J; Gupta R
Pathology; 2023 Jun; 55(4):456-465. PubMed ID: 37055331
[TBL] [Abstract][Full Text] [Related]
15. Glial fibrillary acidic protein and CD57 immunolocalization in cell block preparations is a useful adjunct in the diagnosis of pleomorphic adenoma.
Shah SS; Chandan VS; Wilbur DC; Khurana KK
Arch Pathol Lab Med; 2007 Sep; 131(9):1373-7. PubMed ID: 17824792
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of progesterone receptors in pleomorphic adenoma and adenoid cystic carcinoma.
Safoura S; Mohamad E; Nosrat-Allah E; Fereshte E
J Cancer Res Ther; 2011; 7(1):23-8. PubMed ID: 21546738
[TBL] [Abstract][Full Text] [Related]
17. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.
von Holstein SL
Acta Ophthalmol; 2013 Nov; 91 Thesis 6():1-28. PubMed ID: 24893972
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing adenoid cystic carcinoma from cylindromatous adenomas in salivary fine-needle aspirates: the cytologic clues and their ultrastructural basis.
Yang GC; Waisman J
Diagn Cytopathol; 2006 Apr; 34(4):284-8. PubMed ID: 16544336
[TBL] [Abstract][Full Text] [Related]
19. Fine needle aspiration of pleomorphic adenoma and adenoid cystic carcinoma of salivary gland origin.
Kapadia SB; Dusenbery D; Dekker A
Acta Cytol; 1997; 41(2):487-92. PubMed ID: 9100785
[TBL] [Abstract][Full Text] [Related]
20. Adenoid cystic carcinoma of the lacrimal gland is frequently characterized by MYB rearrangement.
Chen TY; Keeney MG; Chintakuntlawar AV; Knutson DL; Kloft-Nelson S; Greipp PT; Garrity JA; Salomao DR; Garcia JJ
Eye (Lond); 2017 May; 31(5):720-725. PubMed ID: 28085142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
